Tools for clinical pharmacists to identify medications that can cause drug-induced cognitive impairment: A systematic review

被引:0
|
作者
Stanton, Jacob [1 ]
Gionfriddo, Michael R. [2 ]
Rattinger, Gail B. [3 ]
Fang, Yuan [3 ]
Lussier, Mia E. [4 ]
机构
[1] Binghamton Univ, Sch Pharm & Pharmaceut Sci, Binghamton, NY USA
[2] Duquesne Univ, Sch Pharm, Div Pharmaceut Adm & Social Sci, Pittsburgh, PA USA
[3] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Binghamton, NY USA
[4] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharm Practice, Binghamton, NY 13902 USA
关键词
adverse effects; cognitive dysfunction; potentially inappropriate medications; ANTICHOLINERGIC DRUGS; RISK;
D O I
10.1002/jac5.2049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cognitive impairment affects around 19% of community-dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive-impairing medications through cognitive-focused medication reviews or as part of comprehensive medication management. Multiple tools exist to help pharmacists and other practitioners identify these medications, yet a comprehensive description of these tools has not been undertaken. We searched EBSCO MEDLINE, PubMed, EMBASE, CINAHL, and PsycInfo from inception to August 4, 2023, using search terms relative to medications and cognition. Studies were included if they detailed a tool to assess the cognitive burden of a medication regimen. Abstracts and full texts were screened independently and in duplicate. Any disagreements at the level of full-text screening were resolved by consensus. Eligible studies underwent data extraction by two authors independently and in duplicate using a data extraction form. Our search identified 13 126 articles of which only four tools were initially included. Additionally, we identified seven articles from the reference lists of excluded review articles for a final inclusion count of 11 tools. Articles were published between 2001 and 2017. Nine of 11 tools (82%) were focused solely on anticholinergic medications, while only one tool indicated a clinically relevant cutoff value and alternative medication recommendations. While there are many tools to assess the cognitive burden from medications, many are limited by the development date, focus on anticholinergic medications, or lack clinically useful information. Further research is needed to develop more comprehensive, up-to-date, and readily implementable tools that clinical pharmacists can utilize to assess medication-induced cognitive risks. Such as tool could be applied by pharmacists in many settings to optimize medication use and improve patient outcomes.
引用
收藏
页码:1207 / 1227
页数:21
相关论文
共 50 条
  • [41] Drug-induced hyperphagia: What can we learn from psychiatric medications?
    Jensen, Gordon L.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2008, 32 (05) : 578 - 581
  • [42] Drug-Induced Thrombocytopenia An Updated Systematic Review, 2008
    Swisher, Karen K.
    Li, Xiaoning
    Vesely, Sara K.
    George, James N.
    DRUG SAFETY, 2009, 32 (01) : 85 - 86
  • [43] Drug-Induced ThrombocytopeniaAn Updated Systematic Review, 2012
    Zayd L. Al-Nouri
    James N. George
    Drug Safety, 2012, 35 (8) : 693 - 694
  • [44] Drug-induced pemphigus: A systematic review of 170 patients
    Ghaedi, Forugh
    Etesami, Ifa
    Aryanian, Zeinab
    Kalantari, Yasamin
    Goodarzi, Azadeh
    Teymourpour, Amir
    Tavakolpour, Soheil
    Mahmoudi, HamidReza
    Daneshpazhooh, Maryam
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
  • [45] Drug-Induced Thrombocytopenia An Updated Systematic Review, 2012
    Al-Nouri, Zayd L.
    George, James N.
    DRUG SAFETY, 2012, 35 (08) : 693 - 694
  • [46] Drug-Induced ThrombocytopeniaAn Updated Systematic Review, 2006
    Xiaoning Li
    Karen K Swisher
    Sara K. Vesely
    James N. George
    Drug Safety, 2007, 30 : 185 - 186
  • [48] Drug-Induced Interstitial Lung Disease: A Systematic Review
    Skeoch, Sarah
    Weatherley, Nicholas
    Swift, Andrew J.
    Oldroyd, Alexander
    Johns, Christopher
    Hayton, Conal
    Giollo, Alessandro
    Wild, James M.
    Waterton, John C.
    Buch, Maya
    Linton, Kim
    Bruce, Ian N.
    Leonard, Colm
    Bianchi, Stephen
    Chaudhuri, Nazia
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (10):
  • [49] A systematic review of drug-induced subacute cutaneous lupus
    Grau, R.
    Henderson, C. L.
    Sontheimer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (06) : 1606 - 1606
  • [50] Drug-Induced ThrombocytopeniaAn Updated Systematic Review, 2010
    Long Nguyen
    Jessica Reese
    James N. George
    Drug Safety, 2011, 34 : 437 - 438